Letters to HCPs

Important information for Healthcare Professionals

Febuxostat (ADENURIC) DHPC 27 June 2019

Febuxostat (ADENURIC): increased risk of cardiovascular death and all-cause mortality in patients treated with febuxostat in the CARES study

For Healthcare Professionals